SPP1 and hepatocellular carcinoma: Eun, J. W. and colleagues revealed that CAF-secreted SPP1 could reinforce HCC TKI resistance via activating RAF/MAPK and PI3K/AKT/mTOR signaling and favors EMT as well, indicating that SPP1 blockade may have clinical value [447].